SCHEMBL7038396

SCHEMBL7038396

COc1ccc([C@](C)(N)C(=O)Nc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.55
NPC1 O15118 8/20 0.55
SMN1; SMN2 Q16637 7/20 0.55
GAA P10253 3/20 0.55
ALDH1A1 P00352 3/20 0.55
HTT P42858 2/20 0.55
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
KCNK9 Q9NPC2 1/20 0.50
KDM4E B2RXH2 1/20 0.49
TP53 P04637 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 3/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036861 0.86 MEN1 (0.54) RAB9ANPC1SMN1; SMN2ALDH1A1PDK1
SCHEMBL9235174 0.85 RAB9A (0.55) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL22185077 0.79 HDAC3 (0.62) RAB9ANPC1SMN1; SMN2GAAALDH1A1
SCHEMBL3492765 0.77 MAPT (0.50) RAB9ASMN1; SMN2ALDH1A1CYP1A2LMNA
SCHEMBL3491598 0.77 MAPT (0.50) RAB9ASMN1; SMN2ALDH1A1CYP1A2LMNA
SCHEMBL2910709 0.77 MAPT (0.50) RAB9ASMN1; SMN2ALDH1A1CYP1A2LMNA
Hydrochloric Acid SCHEMBL1971295 0.76 MAPT (0.49) RAB9ASMN1; SMN2ALDH1A1CYP1A2LMNA
SCHEMBL1968658 0.76 MAPT (0.53) RAB9ANPC1SMN1; SMN2ALDH1A1PDK1
SCHEMBL1969077 0.76 MAPT (0.53) RAB9ANPC1SMN1; SMN2ALDH1A1PDK1
Hydrochloric Acid SCHEMBL1971292 0.76 MAPT (0.49) RAB9ASMN1; SMN2ALDH1A1CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed